Apr 09, 2020
Crohn's & Colitis Foundation Welcomes New National Trustees
Mar 31, 2020
InDex Pharmaceuticals Receives Grant From Vinnova for Pre-clinical Development of DIMS Compounds in Inflammation
Feb 19, 2020
New Data Show Oral Ferric Maltol (FERACCRU®) May Be a Cost-effective Alternative to Intravenous (IV) Carboxymaltose With at Least as Great Benefits in the Quality of Life of Patients With Iron Deficiency Anaemia and Inflammatory Bowel Disease
Feb 12, 2020
Synspira Therapeutics and Cystic Fibrosis Foundation Sign Agreement to Develop Broad-spectrum Enzyme Replacement for Malabsorption Syndromes
Feb 03, 2020
Palette Life Sciences Launches MySolesta.com, a New Online Resource for Bowel Incontinence to Support Healthcare Professionals, Caregivers and Patients
Jan 07, 2020
VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases
Sep 09, 2019
ExeGi Pharma Probiotics to be Studied in Multiple Sclerosis Patients
Aug 14, 2019
Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health
Jul 31, 2019
Gastric Electric Stimulators Market to Reach a 6.4% of CAGR by 2026 - PMR
Jul 29, 2019
Soligenix Receives European Patents for Oral BDP in the Treatment of Acute Radiation Injury of the Gastrointestinal Tract
Jul 23, 2019
Gastrointestinal Bleeding Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026
May 17, 2019
Crohn's & Colitis UK and Ampersand Health Partner to Create Innovative App to Help People With Crohn's and Colitis
May 17, 2019
U.S. FDA Approves GATTEX® (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Apr 25, 2019
Global Bowel Management Systems Markets to 2023: C.R.Bard, Medtronic, and B.Braun Melsungen Contribute to North America's Dominance
Mar 18, 2019
Understanding Pediatric Chronic Illnesses
Jan 21, 2019
Navigating the Obstacles of Disease Treatment
Jan 14, 2019
Janssen's Stelara and Pfizer's Xeljanz Battle Takeda's Entyvio to Claim the Preferred Alternate Mechanism of Action Position in Inflammatory Bowel Disease Patients Who Are Being Switched from Their Current Treatment
Jan 08, 2019
Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease
Dec 28, 2018
Aerodiagnostics Welcomes Dr. Kathleen O'Neil-Smith as Medical Director
Dec 12, 2018
Trans-Atlantic study finds promising results with Visbiome Vet, a high potency probiotic, in dogs with severe form of acute diarrhea